Myelodysplastic Syndromes (MDS) and acute myeloid leukemia (AML) are rare hematologic malignancies of the bone marrow. They can occur spontaneously or secondary to treatment for other cancers, so called therapy related disease, ...
Jan 21, 2021
0
2
According to an open-access article in ARRS' American Journal of Roentgenology (AJR), fluorine-18-labeled fluciclovine PET/MRI demonstrated utility in the initial staging of high-risk prostate cancer, as well as for evaluating ...
Oct 27, 2020
0
2
(HealthDay)—Promoting any emerging COVID-19 vaccine to a skeptical public could be tough.
Oct 20, 2020
3
2
Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children's Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) ...
Sep 28, 2020
0
3
On March 28, the Food and Drug Administration (FDA) exercised its Emergency Use Authorization (EUA) authority to allow the use of hydroxychloroquine for the treatment of COVID-19. On June 15, after a number of studies failed ...
Aug 31, 2020
0
49
Ohio Gov. Mike DeWine tweeted early Thursday that he had tested positive for the coronavirus and would not be greeting President Donald Trump. Hours later, DeWine announced that two different tests had come back negative.
Aug 12, 2020
0
1
A new prescription head lice treatment, developed by University of Melbourne Associate Professor Vern Bowles, has been given Food and Drug Administration (FDA) approval, allowing it to be sold in the U.S..
Aug 04, 2020
1
3
(HealthDay)—The U.S. Food and Drug Administration is warning consumers not to use alcohol-based hand sanitizers containing methanol, or wood alcohol, which is used in fuel and antifreeze and is toxic if absorbed through ...
Jul 28, 2020
0
3
Given the death, suffering, social disruption and economic devastation caused by COVID-19, there is an urgent need to quickly develop therapies to treat this disease and prevent the spread of the virus.
Jun 10, 2020
0
4
Research into the development of a new vaginal gel, initiated by UniSA Pharmaceutical Scientist, Professor Sanjay Garg, has now been approved by the US FDA as the first and only non-hormonal contraceptive.
Jun 04, 2020
0
1
